Validation of the Patient Neurotoxicity Questionnaire (PNQ) During Taxane Chemotherapy in a Phase III Randomized Trial in Patients with Breast Cancer: N-SAS BC 02

1 University of Marketing and Distribution Sciences, Kobe, Japan; 2 Public Health Research Foundation, Tokyo, Japan; 3 University of Tokyo, Tokyo, Japan; 4 Kyoto University, Kyoto, Japan; 5 National Shikoku Cancer Center, Matsuyama, Japan; 6 Kawasaki Medical School, Kurashiki, Japan; 7 Showa University Toyosu Hospital, Tokyo, Japan; 8 Niigata Prefectural Sakamachi Hospital, Niigata, Japan; 9 International University of Health and Welfare, Tokyo, Japan; 10 BioNumerik Pharmaceuticals, Inc. San Antonio, United States